These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22947076)

  • 1. Beta-blocker use and COPD mortality: a systematic review and meta-analysis.
    Etminan M; Jafari S; Carleton B; FitzGerald JM
    BMC Pulm Med; 2012 Sep; 12():48. PubMed ID: 22947076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
    Suissa S; Ernst P
    COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Quint JK
    BMJ Open; 2018 Nov; 8(11):e024736. PubMed ID: 30429149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
    Du Q; Sun Y; Ding N; Lu L; Chen Y
    PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
    Gulea C; Zakeri R; Alderman V; Morgan A; Ross J; Quint JK
    Respir Res; 2021 Feb; 22(1):64. PubMed ID: 33622362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-blocker is associated with lower mortality in patients with coronary artery disease with or without COPD.
    Rezaei SS; Rinner C; Ratajczak P; Grossmann W; Gall W; Wolzt M
    Clin Respir J; 2018 Dec; 12(12):2627-2634. PubMed ID: 30276967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker under-use in COPD patients.
    Lim KP; Loughrey S; Musk M; Lavender M; Wrobel JP
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3041-3046. PubMed ID: 29089752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.